2
Nature Medicine, Published online: 17 June 2026; doi:10.1038/s41591-026-04473-9
CAR T cell therapy can induce deep responses but also severe toxicities in patients with smoldering myeloma, an asymptomatic cancer precursor; given the potential risks and benefits, its success depends on careful patient selection.
